Elevated soluble Galectin-3 as a marker of chemotherapy efficacy in Breast cancer patients: a prospective study
A. Shafiq, J. Moore, A. Suleman, S. Faiz, O. Farooq, A. Arshad, M. Tehseen, A. Zaffar, S. H. Ali, N. U. Din, A. Loya, N. Siddiqui, F. K. Rehman
This study shows that elevated soluble Galectin-3 in plasma or stromal tissue after chemotherapy correlates with better prognosis and longer disease-free survival in breast cancer patients.
bioRxiv · Feb 27, 2020Cancer Biology